首页> 外文OA文献 >Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines
【2h】

Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines

机译:基于碘的造影剂,多发性骨髓瘤和单克隆血友病:文献复习和ESUR造影剂安全委员会指南

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objectives Many radiologists and clinicians still consider multiple myeloma (MM) and monoclonal gammopathies (MG) a contraindication for using iodine-based contrast media. The ESUR Contrast Media Safety Committee performed a systematic review of the incidence of post-contrast acute kidney injury (PC-AKI) in these patients. Methods A systematic search in Medline and Scopus databases was performed for renal function deterioration studies\udin patients with MM or MG following administration of iodine-based contrast media. Data collection and analysis were performed according to the PRISMA statement 2009. Eligibility criteria and methods of analysis were specified in advance. Cohort and case-control studies reporting changes in renal function were included. Results Thirteen studies were selected that reported 824 iodine-based contrast medium administrations in 642 patients withMMorMG, in which 12 unconfounded cases of PC-AKIwere found (1.6 %). The majority of patients had intravenous urography with high osmolality ionic contrast media after preparatory dehydration and purgation. Conclusions MM and MG alone are not risk factors for PCAKI. However, the risk of PC-AKI may become significant in dehydrated patients with impaired renal function. Hypercalcaemia may increase the risk of kidney damage, and should be corrected before contrast medium administration. Assessment for Bence-Jones proteinuria is not necessary. Key Points • Monoclonal gammopathies including multiple myeloma are a large spectrum of disorders. • In monoclonal \ud gammopathy with normal renal function, PCAKI risk is not increased. • Renal function is often reduced in myeloma, increasing the risk of PC-AKI. • Correction of hypercalcaemia is necessary in myeloma before iodine-based contrast medium administration. • Bence-Jones proteinuria assessment in myeloma is unnecessary before iodine-based contrast medium administration.
机译:目的许多放射科医生和临床医生仍然认为多发性骨髓瘤(MM)和单克隆血友病(MG)是使用基于碘的造影剂的禁忌症。 ESUR造影剂安全委员会对这些患者的造影剂后急性肾损伤(PC-AKI)的发生率进行了系统的回顾。方法在Medline和Scopus数据库中进行系统搜索,以研究基于碘的造影剂后MM或MG患者的肾功能恶化研究。根据PRISMA声明2009进行数据收集和分析。事先指定了资格标准和分析方法。队列和病例对照研究报告了肾功能的变化。结果选择了13项研究,报告了642例MMorMG患者使用824次基于碘的造影剂,其中发现12例无混淆的PC-AKI病例(1.6%)。在准备脱水和通便后,大多数患者接受了高渗透压离子造影剂静脉输尿管造影。结论单独的MM和MG并不是PCAKI的危险因素。但是,在肾功能受损的脱水患者中,PC-AKI的风险可能变得很大。高钙血症可能会增加肾脏损害的风险,应在使用造影剂之前予以纠正。无需评估Bence-Jones蛋白尿。要点•包括多发性骨髓瘤在内的单克隆血友病是多种疾病。 •在肾功能正常的单克隆\ ud球菌病中,PCAKI风险不会增加。 •骨髓瘤的肾功能通常降低,增加了PC-AKI的风险。 •在基于碘的造影剂给药之前,骨髓瘤中必须纠正高钙血症。 •在使用基于碘的造影剂之前,无需对骨髓瘤进行Bence-Jones蛋白尿评估。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号